Free Float 63,94 %
Shares Float 13,56 M
Shares Outstanding 21,21 M
Lipum AB (publ)
Share · SE0015660899 (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Lipum AB (publ)
No Price
Share Float & Liquidity
Company Profile for Lipum AB (publ) Share
Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of pediatric rheumatism and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116. The company was founded in 2010 and is headquartered in Umeå, Sweden.
Company Data
Name Lipum AB (publ)
Company Lipum AB (publ)
Website
https://www.lipum.se
Primary Exchange 
NASDAQ STOCKHOLM AB
NASDAQ STOCKHOLM AB
ISIN SE0015660899
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ola Sandborgh
Market Capitalization 304 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Tvistevägen 48C, 907 36 Umeå
IPO Date 2021-04-22
Stock Splits
| Date | Split |
|---|---|
| 04.04.2024 | 519:500 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | LIPUM.ST |
More Shares
Investors who hold Lipum AB (publ) also have the following shares in their portfolio:
